<DOC>
	<DOCNO>NCT01424228</DOCNO>
	<brief_summary>The purpose trial evaluate long-term ( 24 week ) efficacy prucalopride versus placebo subject age 18 year old chronic constipation .</brief_summary>
	<brief_title>Evaluation Long-term Prucalopride Treatment With Chronic Constipation Subjects Aged ≥ 18 Years</brief_title>
	<detailed_description>In phase IV trial total 340 subject ( 170 subject per treatment group ) , chronic constipation , plan randomly assign double-blind treatment . The trial duration subject 26 28 week total , include 2- 4-week run-in phase follow 24-week double-blind treatment phase . The patient complete e-diary . Adult subject ( ≥18 &lt; 65 year age ) take 2 mg prucalopride match placebo throughout entire 24-week treatment period . Elderly subject ( ≥65 year age ) start dose 1 mg prucalopride match placebo . In case insufficient response daily dose increased 2 mg ( i.e . change 2 mg prucalopride match placebo ) .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Subject male nonpregnant , nonbreastfeeding female outpatient ≥18 year age ( upper age limit ) . 2 . Subject history constipation . The subject report average ≤2 SBM/week result feel complete evacuation ( SCBM ) . 3 . Subject agree stop his/her current laxative treatment willing use rescue medication accord rescue rule [ bisacodyl/enemas ] . 1 . Subjects constipation think druginduced 2 . Subjects use disallowed medication . 3 . Subjects previously use prucalopride . 4 . Subjects suffer secondary cause chronic constipation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Long term</keyword>
	<keyword>Constipation</keyword>
	<keyword>Digestive sign symptom</keyword>
</DOC>